
How Nanobiotechnology and Bioinformatics Are Shaping the Future of Healthcare
Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.
Showing results for: "future drug" (86 results)

Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.

This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, claiming over a million lives each year. TB is the deadliest infectious disease known today, claiming more lives than COVID-19. TB is caused by the bacterium Mycobacterium tuberculosis. TB spreads through the air when infected people breathe, cough, sneeze,

(DCTs) are redefining how pharmaceutical studies are designed, conducted, and analyzed by moving away from traditional site-centric models toward patient-centric, digitally enabled trial ecosystems.

Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.

Inhaled antibiotics deliver drugs directly to lung infections, achieving better results with fewer side effects, which is a game-changer in fighting resistance.

ears pass in schoolrooms where future doctors study life's inner workings, cells, chemicals, and body parts. From books they recall illness patterns, how molecules bond, ways to spot health troubles

Antibiotic resistance is making common infections hard to treat. Learn why it happens, how it affects communities in Nigeria and beyond, and what we can do to protect these life-saving medicines.

Animal models have traditionally served as the cornerstone of drug safety evaluation; however, major translational challenges persist due to interspecies differences in physiology, metabolism, and genetic regulation. Many compounds demonstrating favorable toxicity profiles in animals later fail during human trials or are withdrawn post-marketing due to unforeseen adverse effects, especially hepatotoxicity and cardiotoxicity (Lee et al., 2025).

Antibiotic resistance could kill 10 million annually by 2050. Discover how AI found Halicin, a molecule that kills superbugs humans couldn't defeat.

Nanotechnology is having a big impact on pharmaceutical sciences, and drug delivery systems are one area where this is most evident. Compared to conventional medication delivery methods, nanoparticles provide a number of benefits, including increased effectiveness and fewer adverse drug reactions.

Epigenetics is transforming how scientists understand the bridge between genes and behavior, opening the door to a new era of mental health treatment.

The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,

Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.

As global data generation continues to grow exponentially, traditional storehouse innovations face challenges related to capacity, energy consumption, and long- term preservation. DNA data storehouse offers a revolutionary result by garbling computerized information into synthetic DNA molecules. This explores DNA data storage, its basics, uses, benefits, and ethics, and how it could change future data archiving.

Natural polysaccharides like locust bean gum and chitosan are replacing lactose as safer, more effective carriers for inhaled medications and vaccines.

Why is mucus the biggest obstacle to lung drug delivery? Explore the mucosal barrier science reshaping how we design inhaled medicines and vaccines.

Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.

Too big, it hits your throat. Too small, you exhale it. The sweet spot delivers drugs exactly where they're needed.

From innovative methods for cancer treatment to understanding the complexities of the human gut biome, these discoveries not only enhance our comprehension of the world but also lay the foundation for future groundbreaking advancements.